Highlights of the year

Members of the WHO Programme
for International Drug Monitoring
UMC publications
Gattepaille L.
Using the WHO database of spontaneous reports to build joint vector representations of drugs and adverse drug reactions, a promising avenue for pharmacovigilance. 2019 IEEE International Conference on Healthcare Informatics (ICHI), Xi'an, China, 2019, pp. 1-6, doi: 10.1109/ICHI.2019.8904551.
van Stekelenborg J, Ellenius J, Maskell S, Bergvall T, Caster O et al 
Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR. Drug Safety, Vol. 42, 1393–1407(2019)
Date: 2019-08-24
Rocca E, Copeland S, Edwards IR  
Pharmacovigilance as Scientific Discovery: An Argument for Trans-DisciplinarityDrug Safety, Vol. 42, 1115–1124 (2019)
Date: 2019-10-01
Watson S, Caster O, Rochon PA, den Ruijter H 
Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a centuryEClinicalMedicine. 2019 Oct 25;17:100188
Date: 2019-10-25
Wakao R, Taavola H, Sandberg L, Iwasa E, Soejima S, Chandler RE, Norén GN
Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety ReportsDrug Safety, Vol. 42, 1487–1498 (2019)
Date: 2019-12-02
Dietrich J, Gattepaille L, Anne Grum B, Jiri L, Lerch M, Sartori D, Wisniewski A
Adverse Events in Twitter - Development of a Benchmark Reference Dataset: Results from IMI WEB-RADRDrug Safety (2020) 43:467–478.
Date: 2020-01-29
de Leon J, J. Sanz E, Norén GN, De las Cuevas C
Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second‐generation antipsychoticsWorld Psychiatry. 2020 Feb; 19(1): 120–121. Published online 2020 Jan 10. doi: 10.1002/wps.20707
Date: 2020-02-03
Lagerlund O, Strese S, Fladvad M, Lindquist M
WHODrug: A Global, Validated and Updated Dictionary for Medicinal InformationTher Innov Regul Sci. 2020 Feb 20. doi: 10.1007/s43441-020-00130-6
Date: 2020-02-20
​​​​​​​Chandler RE, McCarthy D, Delumeau JC, Harrison-Woolrych M
The Role of Pharmacovigilance and ISoP During the Global COVID-19 PandemicDrug Saf. 2020 Jun;43(6):511-512. doi: 10.1007/s40264-020-00941-4
Date: 2020-05-07
Chandler RE 
Optimizing safety surveillance for COVID-19 vaccinesNat Rev Immunol. 2020 Jun 17:1–2. doi: 10.1038/s41577-020-0372-8.
Date: 2020-06-17
Sandberg L, Taavola H, Aoki Y, Chandler R, Norén GN. 
Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBaseDrug Saf. 2020 Jun 20. doi: 10.1007/s40264-020-00957-w.
Date: 2020-06-20
Härmark L, Weits G, Meijer R, Santoro F, Norén GN, van Hunsel F. 
Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the NetherlandsDrug Saf. 2020 May 16. doi: 10.1007/s40264-020-00932-5.
Date: 2020-06-25
Furlan G, Caduff-Janosa P, Sottosanti L, Cappello E, Valdiserra G, Tuccori M. 
Drug Safety in Geriatric Patients: Current Status and Proposed Way ForwardDrug Saf. 2020 Jun 4. doi: 10.1007/s40264-020-00949-w
Date: 2020-06-25

Gattepaille LM, Hedfors Vidlin S, Bergvall T, Pierce CE, Ellenius J
Prospective Evaluation of Adverse Event Recognition Systems in Twitter: Results from the Web-RADR Project
Drug Saf. 2020 May 14. doi: 10.1007/s40264-020-00942-3
Date: 2020-06-25
Chandler RE 
Nintedanib and ischemic colitis: Signal assessment with the integrated use of two types of real-world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from large health-care databasesPharmacoepidemiol Drug Saf. 2020 May 12. doi: 10.1002/pds.5022
Date: 2020-06-25
Hult S, Sartori D, Bergvall T, Hedfors Vidlin S, Grundmark B, Ellenius J, Norén GN
A Feasibility Study of Drug–Drug Interaction Signal Detection in Regular Pharmacovigilance. Drug Safety, Vol. 43, 775–785 (2020).
Date: 2020-07-17

You may also like

Back to Top